We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alexandria Secures Lease at Its Megacampus in San Diego
Read MoreHide Full Article
Key Takeaways
ARE signs a 16-year lease for 466,598 RSF at Campus Point Megacampus, its 31-year largest life science lease.
The build-to-suit San Diego research hub targets LEED Gold Core & Shell, Fitwel and 100% electrification.
Campus Point Megacampus may grow to 2.6M RSF, a 420% scale jump since its first acquisition.
Alexandria Real Estate Equities, Inc. (ARE - Free Report) secured the largest life science lease in its 31 years of history by signing a 16-year lease agreement with a longtime multi-national pharmaceutical tenant. The lease for this build-to-suit research hub spans over 466,598 rentable square feet (RSF) of space located at Campus Point by Alexandria Megacampus in the University Town Center submarket of San Diego.
This lease highlights the demand for Alexandria's premier location for life science innovation in San Diego.
The construction of this development project, aimed at achieving 100% electrification along with LEED Gold Core & Shell and Fitwel certifications, is set to begin in 2026, with an expected completion in 2028. This high-performance laboratory facility emphasizes energy efficiency and minimizes water consumption, alongside focusing on the health and wellness of its occupants. Its distinctive design incorporates natural light, optimizes shared spaces to encourage connectivity and includes a spacious terrace that functions as a central gathering area, seamlessly integrating indoor and outdoor spaces.
In 1994, Alexandria took the lead in life science real estate with its founding and first acquisition in San Diego. Since the acquisition of its first Campus Point property in 2010, the company has been carefully aggregating, designing, entitling, developing and transforming assets to create an irreplicable Megacampus ecosystem featuring a solid and diverse tenant base, which drives high-quality long-term cash flows.
As of June 30, 2025, Campus Point comprises 1.3 million RSF in operation and is 98.8% occupied. With nearly 1.3 million RSF of additional future development and redevelopment opportunities, this Megacampus could potentially expand to about 2.6 million RSF, reflecting 420% growth in its scale from the initial acquisition.
The campus is well-positioned to provide tenants with crucial expansion space and an enhanced amenity experience, which aids in recruiting and retaining mission-critical talent to foster next-generation innovations.
Alexandria in a Snapshot
Alexandria is the preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Alexandria caters to a diversified tenant base comprising high-quality companies ranging from multinational pharmaceutical companies, public and private biotechnology companies, manufacturers of complex medicines and top-tier investment-grade companies and institutions as well as technology entities. However, with a substantial concentration of companies belonging to the life science and technology industries, Alexandria’s performance remains susceptible to any changes within these industries.
The company’s substantial active development and redevelopment pipeline, although encouraging for long-term growth, exposes it to the risk of rising construction costs and lease-up concerns amid macroeconomic uncertainty.
In the past three months, shares of this Zacks Rank #5 (Sell) company have gained 2% compared with the industry's rise of 5.3%.
The Zacks Consensus Estimate for SBAC’s 2025 FFO per share has moved 3 cents northward to $12.74 over the past two months.
The Zacks Consensus Estimate for AMT’s 2025 FFO per share has moved 2 cents northward to $10.55 over the past week.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Alexandria Secures Lease at Its Megacampus in San Diego
Key Takeaways
Alexandria Real Estate Equities, Inc. (ARE - Free Report) secured the largest life science lease in its 31 years of history by signing a 16-year lease agreement with a longtime multi-national pharmaceutical tenant. The lease for this build-to-suit research hub spans over 466,598 rentable square feet (RSF) of space located at Campus Point by Alexandria Megacampus in the University Town Center submarket of San Diego.
This lease highlights the demand for Alexandria's premier location for life science innovation in San Diego.
The construction of this development project, aimed at achieving 100% electrification along with LEED Gold Core & Shell and Fitwel certifications, is set to begin in 2026, with an expected completion in 2028. This high-performance laboratory facility emphasizes energy efficiency and minimizes water consumption, alongside focusing on the health and wellness of its occupants. Its distinctive design incorporates natural light, optimizes shared spaces to encourage connectivity and includes a spacious terrace that functions as a central gathering area, seamlessly integrating indoor and outdoor spaces.
In 1994, Alexandria took the lead in life science real estate with its founding and first acquisition in San Diego. Since the acquisition of its first Campus Point property in 2010, the company has been carefully aggregating, designing, entitling, developing and transforming assets to create an irreplicable Megacampus ecosystem featuring a solid and diverse tenant base, which drives high-quality long-term cash flows.
As of June 30, 2025, Campus Point comprises 1.3 million RSF in operation and is 98.8% occupied. With nearly 1.3 million RSF of additional future development and redevelopment opportunities, this Megacampus could potentially expand to about 2.6 million RSF, reflecting 420% growth in its scale from the initial acquisition.
The campus is well-positioned to provide tenants with crucial expansion space and an enhanced amenity experience, which aids in recruiting and retaining mission-critical talent to foster next-generation innovations.
Alexandria in a Snapshot
Alexandria is the preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Alexandria caters to a diversified tenant base comprising high-quality companies ranging from multinational pharmaceutical companies, public and private biotechnology companies, manufacturers of complex medicines and top-tier investment-grade companies and institutions as well as technology entities. However, with a substantial concentration of companies belonging to the life science and technology industries, Alexandria’s performance remains susceptible to any changes within these industries.
The company’s substantial active development and redevelopment pipeline, although encouraging for long-term growth, exposes it to the risk of rising construction costs and lease-up concerns amid macroeconomic uncertainty.
In the past three months, shares of this Zacks Rank #5 (Sell) company have gained 2% compared with the industry's rise of 5.3%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks from the broader REIT sector include SBA Communications (SBAC - Free Report) and American Tower (AMT - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for SBAC’s 2025 FFO per share has moved 3 cents northward to $12.74 over the past two months.
The Zacks Consensus Estimate for AMT’s 2025 FFO per share has moved 2 cents northward to $10.55 over the past week.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.